Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Large Cap

Large Cap

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Asia
  • General
  • Health Care
  • Large Cap
  • Markets
  • News

AstraZeneca Mulls China Business Unit Spin-Off Amid Geopolitical Tensions

By Vandana Singh
June 20, 8:23 AM
European drugmaker AstraZeneca plc (NASDAQ: AZN) is reportedly drafting a plan to spin off its China business, and listing a separate unit in Hong Kong is considered an option amid mounting geopolitical tensions.

AZN

Read More
1 minute read
  • Equities
  • Large Cap
  • Markets
  • Media
  • News
  • Penny Stocks

Grab Plans To Cut Headcount By 5%, Biggest Reduction Since Pandemic: Report

By Lekha Gupta
June 20, 7:49 AM
Grab Holdings Inc (NASDAQ: GRAB) is reportedly planning its biggest round of job cuts since the pandemic.

GRAB

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • Movers
  • News

Sanofi Stock Is Trading Higher Today – Here’s Why

By Vandana Singh
June 20, 7:47 AM
Sanofi SA (NASDAQ: SNY) announced that the tribunal dismissed Boehringer Ingelheim's indemnification claim against Sanofi in an International Chamber of Commerce dispute in cancer lawsuits linked to heartburn drug 

GSK

Read More
1 minute read
  • Contracts
  • Equities
  • General
  • Large Cap
  • Markets
  • News

Stellantis, Foxconn Form Joint Venture To Develop Chips Aimed At Automotive Industry

By Shivani Kumaresan
June 20, 5:46 AM
Stellantis NV (NYSE: STLA) and Hon Hai Technology Group (Foxconn) has formed a joint venture SiliconAuto to tailor chips aimed at the new generation of automotive industry vehicle 

STLA

Read More
1 minute read
  • Equities
  • Large Cap
  • M&A
  • Markets
  • News

BorgWarner Buys Eldor’s EHS Business, Boosting ePropulsion Portfolio

By Lekha Gupta
June 20, 5:08 AM
BorgWarner Inc (NYSE: BWA) stated its plans to acquire Eldor Corporation's Electric Hybrid Systems (EHS) business 

BWA

Read More
1 minute read
  • Equities
  • Eurozone
  • Large Cap
  • Markets
  • News
  • Tech
  • Top Stories

Intel Discloses $32.7B Investment In Germany, Projects Creation Of More Than 10,000 Jobs

By Lekha Gupta
June 19, 2:22 PM
Intel Corp (NASDAQ: INTC) disclosed an investment Monday of over 30 billion euros ($32.7 billion) in Germany to expand its manufacturing capacity in

INTC

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Equities
  • Large Cap
  • Markets
  • News
  • Price Target
  • Real Estate
  • REIT
  • Reiteration

Analyst Expects Equinix To Raise Long-Term Outlook At Upcoming Investor Day

By Lekha Gupta
June 16, 1:55 PM
BMO Capital Markets analyst Ari Klein raised the price target of Equinix Inc (NASDAQ: EQIX) to $870 

EQIX

Read More
2 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Merck’s Keytruda Combo Therapy Hits Primary Goal In Patients With Rare Form Of Gastric Cancer

By Vandana Singh
June 16, 1:50 PM
Merck & Co Inc (NYSE: MRK) announced topline data from the Phase 3 KEYNOTE-811 trial of Keytruda (pembrolizumab) plus trastuzumab and chemotherapy for human epidermal growth factor receptor 2 (HER2)-positive advanced gastric or 

MRK

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

Eli Lilly’s Migraine Candidate Flunks Head-To-Head Study With Pfizer’s Newly Acquired Drug

By Vandana Singh
June 16, 1:48 PM
Eli Lilly And Co (NYSE: LLY) announced the results of the CHALLENGE-MIG clinical trial of Emgality (galcanezumab-gnlm) and Nurtec ODT (rimegepant orally disintegrating tablet).

LLY

Read More
2 minute read
  • Equities
  • General
  • Large Cap
  • News
  • Tech
  • Top Stories

Meta’s AI Voicebox Aims To Do For Audio What ChatGPT, Dall-E Did For Text, Image Generation

By AJ Fabino
June 16, 11:59 AM
Meta Platforms Inc (NASDAQ:META) CEO Mark Zuckerberg on Friday introduced Voicebox, a text-to-speech (TTS) generative artificial intelligence speech…

META

Posts pagination

Previous 1 … 288 289 290 … 437 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service